Kroger, Walgreen’s Sue J&J for Suppressing Remicade Biosimilars

Drug Industry Daily
A A
Two major drug store chains sued Johnson & Johnson this week alleging the company strong-armed insurers out of covering biosimilars of its immunosuppressant drug Remicade (infliximab).

To View This Article:

Login

Subscribe To Drug Industry Daily